Coronavirus disease 2019 (COVID-19) is a disease caused by infection with the SARS-CoV-
2 virus and has represented one of the greatest challenges humanity has faced in recent …

Infection with SARs-COV-2 displays increasing fatality with age and underlying co-morbidity,
in particular, with markers of the metabolic syndrome and diabetes, which seems to be …

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is one of the most severe
global pandemic due to its high pathogenicity and death rate starting from the end of 2019 …

In December 2019, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
started spreading worldwide causing the coronavirus disease 2019 (COVID-19) pandemic …

The COVID-19 pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2), has created an urgent global situation. Therefore, it is necessary to identify …

The outbreak of COVID‐19 emerged in December 2019 rapidly spread across the globe and
has become pandemic. Little is known about the protective factors of this infection, which is …

Coronavirus disease 2019 (COVID-19) is a highly contagious viral disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has various effects on …

Objectives The aim of this study was to analyze whether subgroups of immunosuppressive
(IS) medications conferred different outcomes in COVID-19. Methods The study involved a …

Aims Several reports indicate that diabetes determines an increased mortality risk in patients
with coronavirus disease 19 (COVID‐19) and a good glycaemic control appears to be …

Kidney transplant recipients (KTRs) are at increased risk for a more severe course of COVID-
19, due to their pre-existing comorbidity and immunosuppression. Consensus protocols …